Your browser doesn't support javascript.
loading
Oleuropein reduces LPS-induced inflammation via stimulating M2 macrophage polarization.
Mirsanei, Zahra; Heidari, Neda; Hazrati, Ali; Asemani, Yahya; Niknam, Bahare; Yousefi, Zahra; Jafari, Reza.
Afiliación
  • Mirsanei Z; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Heidari N; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Hazrati A; Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Asemani Y; Student Research Committee, Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Niknam B; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Yousefi Z; School of Allied Medical Sciences, Shahroud University of Medical Sciences, Shahroud, Iran.
  • Jafari R; School of Allied Medical Sciences, Shahroud University of Medical Sciences, Shahroud, Iran. Electronic address: Jafari.r@shmu.ac.ir.
Biomed Pharmacother ; 163: 114857, 2023 Jul.
Article en En | MEDLINE | ID: mdl-37178576
Oleuropein (OLEU) is the most prevalent phenolic component in olive varieties, and it has been considered for its powerful antioxidant properties in therapeutic applications. OLEU has anti-inflammatory properties and performs this property by suppressing inflammatory cells' function and reducing oxidative stress caused by various factors. This study investigated the ability of OLEU to polarize LPS-stimulated murine macrophage (MQ) cell RAW 264.7 into M1/M2 macrophages. As a first step, the cytotoxicity effects of OLEU were evaluated on LPS-stimulated RAW 264.7 cells using the thiazolyl blue (MTT) colorimetric test. Then, cytokines production, gene expression (Real-Time PCR), and functions (Nitrite oxide assay and phagocytosis assay) of OLEU-treated LPS-stimulated RAW 264.7 cells were evaluated. Our findings demonstrated that OLEU could reduce nitrite oxide (NO) production in LPS-stimulated RAW 264.7 cells by downregulating the inducible nitric oxide synthase gene expression. Furthermore, OLEU therapy decreases the expression of M1-associated pro-inflammatory cytokines production (IL-12, IFN-γ, and TNF-α) and genes expression (iNOS, TNF-α) while increasing the M2-associated anti-inflammatory gene expression and cytokines production (IL-10, and TGF-ß). Based on the result, OLEU may be considered a potential therapeutic approach for inflammatory diseases due to its possible effects on oxidative stress-related factors, cytokine expression and production, and phagocytosis.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Lipopolisacáridos / Factor de Necrosis Tumoral alfa Límite: Animals Idioma: En Revista: Biomed Pharmacother Año: 2023 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Lipopolisacáridos / Factor de Necrosis Tumoral alfa Límite: Animals Idioma: En Revista: Biomed Pharmacother Año: 2023 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Francia